In this clinical trial, magnesium was shown to increase the abundance of certain gut bacteria that are capable of synthesizing vitamin D locally in the intestine. This effect was especially notable in women, which researchers believe may be linked to estrogen’s role in altering magnesium distribution within the body.
Significantly, therefore, there is now convincing evidence linking higher concentrations of vitamin D with a lower risk of colorectal cancer. A study published in 2019 analyzed over 5,700 colorectal cancer cases and 7,100 controls from the United States, Europe, and Asia. People with deficient concentrations of vitamin D were found to have a 31 percent higher risk of colorectal cancer. Conversely, higher concentrations were associated with a lower risk of the disease. Other researchers have found that giving chemotherapy patients high-dose vitamin D delays the progression of metastatic colorectal cancer.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
Mediterranean Diet Leads to 75 Percent Symptom Reduction in Patients with Mild to Moderate Psoriasis
October 3, 2025Tylenol, Autism, and the Media Outrage: Who Really Benefits?
October 3, 2025Magnesium Inhibits Colorectal Cancer Carcinogenesis by Increasing Vitamin D-Synthesizing Bacteria
News
Researchers from Vanderbilt University Medical Center have demonstrated in a precision-based clinical trial that a magnesium supplement increases gut bacteria in humans that have been shown to synthesize vitamin D and inhibit colorectal cancer carcinogenesis.
[Source: medicalxpress.com]
[Image source: Adobe Stock]
Comment
In this clinical trial, magnesium was shown to increase the abundance of certain gut bacteria that are capable of synthesizing vitamin D locally in the intestine. This effect was especially notable in women, which researchers believe may be linked to estrogen’s role in altering magnesium distribution within the body.
Significantly, therefore, there is now convincing evidence linking higher concentrations of vitamin D with a lower risk of colorectal cancer. A study published in 2019 analyzed over 5,700 colorectal cancer cases and 7,100 controls from the United States, Europe, and Asia. People with deficient concentrations of vitamin D were found to have a 31 percent higher risk of colorectal cancer. Conversely, higher concentrations were associated with a lower risk of the disease. Other researchers have found that giving chemotherapy patients high-dose vitamin D delays the progression of metastatic colorectal cancer.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
Dr. Rath Health Foundation
Related posts
Japan Sets Record of Nearly 100,000 People Aged Over 100
Read more